Suppr超能文献

围手术期患者应用低氯与高氯含量静脉溶液:系统评价与荟萃分析。

Low- versus High-Chloride Content Intravenous Solutions for Perioperative Patients: A Systematic Review and Meta-Analysis.

机构信息

ICU, DongE Hospital Affiliated to Shandong First Medical University, Liaocheng, China.

Education Department, DongE Hospital Affiliated to Shandong First Medical University, Liaocheng, China.

出版信息

Biomed Res Int. 2021 Jan 2;2021:3571397. doi: 10.1155/2021/3571397. eCollection 2021.

Abstract

BACKGROUND

Studies have shown complications of normal saline infusion because of its high-chloride content. Therefore, in the present study, we aimed to explore whether the use of low- versus high-chloride solutions benefited the unselected and specifically perioperative patients and was associated with different outcomes.

METHODS

Studies on the use of low- versus high-chloride content intravenous solutions for perioperative patients, published up to July 15, 2019, were systematically reviewed, and primary and secondary outcomes were quantitatively summarized.

RESULTS

A total of 14 eligible randomized controlled trials with 943 perioperative patients were included. Five studies reported all-cause mortality, and eight studies provided detailed data on renal replacement therapy (RRT). The pooled result suggested no statistically significant difference in the effect of low- versus high-chloride solutions on all-cause mortality (risk ratio (RR) = 1.39; 95%confidence interval (CI) = 0.23-8.26) and RRT (RR = 1.05; 95%CI = 0.63-1.76). The pooled results on acute kidney injury (AKI) and the use of allogenic blood transfusion ( > 0.05) were similar.

CONCLUSION

Among specific perioperative patients, the use of low- versus high-chloride content intravenous solutions did not reduce the all-cause mortality, risk of severe AKI, or rate of RRT use. Further large randomized clinical trials are needed to confirm or refute this finding.

摘要

背景

研究表明,由于生理盐水的高氯含量,其输注会引发并发症。因此,在本研究中,我们旨在探讨使用低氯与高氯含量的静脉溶液是否有益于非选择性和特定围手术期患者,并与不同的结果相关。

方法

系统检索了截至 2019 年 7 月 15 日发表的关于围手术期患者使用低氯与高氯含量静脉溶液的研究,并对主要和次要结局进行了定量总结。

结果

共纳入了 14 项符合条件的随机对照试验,涉及 943 例围手术期患者。有 5 项研究报告了全因死亡率,有 8 项研究提供了关于肾脏替代治疗(RRT)的详细数据。汇总结果表明,低氯与高氯溶液对全因死亡率(风险比[RR] = 1.39;95%置信区间[CI] = 0.23-8.26)和 RRT(RR = 1.05;95%CI = 0.63-1.76)的影响无统计学差异。急性肾损伤(AKI)和异体输血(>0.05)的汇总结果也相似。

结论

在特定围手术期患者中,使用低氯与高氯含量的静脉溶液并不能降低全因死亡率、严重 AKI 的风险或 RRT 的使用率。需要进一步的大型随机临床试验来证实或反驳这一发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84b0/7801087/d80575633db6/BMRI2021-3571397.001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验